- Home
- TIL vs ENX Comparison
TIL vs ENX Comparison
Compare TIL & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- ENX
- Stock Information
- Founded
- TIL 2018
- ENX 2002
- Country
- TIL United States
- ENX United States
- Employees
- TIL N/A
- ENX N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- ENX Finance/Investors Services
- Sector
- TIL Health Care
- ENX Finance
- Exchange
- TIL Nasdaq
- ENX Nasdaq
- Market Cap
- TIL 177.1M
- ENX 169.0M
- IPO Year
- TIL 2021
- ENX N/A
- Fundamental
- Price
- TIL $17.27
- ENX $10.00
- Analyst Decision
- TIL Strong Buy
- ENX
- Analyst Count
- TIL 5
- ENX 0
- Target Price
- TIL $100.67
- ENX N/A
- AVG Volume (30 Days)
- TIL 97.5K
- ENX 25.4K
- Earning Date
- TIL 11-13-2025
- ENX 01-01-0001
- Dividend Yield
- TIL N/A
- ENX 3.94%
- EPS Growth
- TIL N/A
- ENX N/A
- EPS
- TIL N/A
- ENX 0.16
- Revenue
- TIL N/A
- ENX N/A
- Revenue This Year
- TIL N/A
- ENX N/A
- Revenue Next Year
- TIL N/A
- ENX N/A
- P/E Ratio
- TIL N/A
- ENX $61.00
- Revenue Growth
- TIL N/A
- ENX N/A
- 52 Week Low
- TIL $10.80
- ENX $7.84
- 52 Week High
- TIL $44.50
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- TIL 40.68
- ENX 67.72
- Support Level
- TIL $17.44
- ENX $9.91
- Resistance Level
- TIL $20.11
- ENX $10.02
- Average True Range (ATR)
- TIL 1.29
- ENX 0.05
- MACD
- TIL -0.00
- ENX -0.01
- Stochastic Oscillator
- TIL 1.61
- ENX 59.37
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.